Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
2015 · Nature Communications · 370 citations
https://doi.org/10.1038/ncomms8629
S
Sophie Lestavel
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
5.1K
Citations
32
h-index
56
i10-index
Sophie Lestavel is an academic researcher from Inserm. The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & Cholesterol and Lipid Metabolism & Peroxisome Proliferator-Activated Receptors. The author has an h-index of 32, co-authored 90 publications.
ORCID: 0000-0001-7839-4757Papers by this author
worksReduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1
2004 · Journal of Lipid Research · 182 citations
https://doi.org/10.1194/jlr.m400400-jlr200
Rexinoid Bexarotene Modulates Triglyceride but not Cholesterol Metabolism via Gene-Specific Permissivity of the RXR/LXR Heterodimer in the Liver
2009 · Arteriosclerosis Thrombosis and Vascular Biology · 73 citations
https://doi.org/10.1161/atvbaha.109.189506
The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
2020 · Scientific Reports · 72 citations
https://doi.org/10.1038/s41598-019-56743-x
Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates
2002 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 26 citations
https://doi.org/10.1016/s1388-1981(02)00188-9
The farnesoid X receptor (FXR) antagonist 7β-isopropylchenodeoxycholic acid improves glucose metabolism in mice on a Western diet
2025 · Pharmacological Research · 3 citations
https://doi.org/10.1016/j.phrs.2025.107950
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat